About Centro de Referencia da Saude da Mulher
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Eurofarma Laboratorios S.A.
1
Clinical Trials at Centro de Referencia da Saude da Mulher
During the past decade, Centro de Referencia da Saude da Mulher conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
2011-03-01
2012-10-01
Completed
220
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
2013-08-26
2028-08-29
Active, not recruiting
450
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
2013-09-03
2023-12-29
Active, not recruiting
327
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Referencia da Saude da Mulher"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Centro de Referencia da Saude da Mulher
According to Clinical.Site data, the most researched conditions in "Centro de Referencia da Saude da Mulher" are
"Advanced Ovarian Cancer" (1 trials), "BRCA Mutated" (1 trials), "BRCA Mutation" (1 trials), "Complete Response" (1 trials) and "FIGO Stage III-IV" (1 trials). Many other conditions were trialed in "Centro de Referencia da Saude da Mulher" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Referencia da Saude da Mulher
Most popular intervention types in "Centro de Referencia da Saude da Mulher" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Olaparib 300mg tablets" (2 trials), "Filgrastim (Eurofarma)" (1 trials), "Filgrastim (Granulokine, Amgen)" (1 trials) and "Placebo to match olaparib 300mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Referencia da Saude da Mulher
The vast majority of trials in "Centro de Referencia da Saude da Mulher" are
3 trials for "Female" genders.
Clinical Trials Status at Centro de Referencia da Saude da Mulher
Currently, there are NaN active trials in "Centro de Referencia da Saude da Mulher".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Centro de Referencia da Saude da Mulher,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Referencia da Saude da Mulher, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".